Reversion and conversion of interferon- release assay results in HIV-1-infected individuals

Journal of Infectious Diseases

Volumn 209, Issue 5, 2014, Pages 729-733

  Aichelburg, Maximilian C ^a   Reiberger, Thomas ^b   Breitenecker, Florian ^a   Mandorfer, Mattias ^b   Makristathis, Athanasios ^b   Rieger, Armin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

conversion; human immunodeficiency virus type 1; interferon gamma release assay; reversion; serial testing

Indexed keywords

CONVERSION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; INTERFERON-GAMMA RELEASE ASSAY; REVERSION; SERIAL TESTING;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; MALE; PROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84894277785     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit418     Document Type: Conference Paper

References (14)

1. Kaufmann SH, McMichael AJ. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med 2005; 11: S33-44.
2. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17:968-75.
3. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immunebased diagnosis of tuberculosis. Lancet 2000; 356:1099-104.
4. Rangaka MX, Wilkinson KA, Seldon R, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2007; 175:514-20.
5. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999; 159:15-21.
6. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010; 59:1-25.
7. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48:954-62.
8. Aichelburg MC, Tittes J, Breitenecker F, Reiberger T, Kohrgruber N, Rieger A. Prognostic value of indeterminate IFN-gamma release assay results in HIV-1 infection. J Clin Microbiol 2012; 50:2767-9.
9. Baker CA, Thomas W, Stauffer WM, Peterson PK, Tsukayama DT. Serial testing of refugees for latent tuberculosis using the QuantiFERON-Gold In-Tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 2009; 80:628-33.
10. Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009; 13:84-92.
11. Pai M, Joshi R, Dogra S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174:349-55.
12. Fong KS, Tomford JW, Teixeira L, et al. Challenges of interferongamma release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012; 142:55-62.
13. Gray J, Reves R, Johnson S, Belknap R. Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis 2012; 54:e20-3.
14. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012; 67:62-70.